Reproductive Medicine Associates (RMA) Expands Access to Exceptional Fertility Care with New Location in East Bay

Third NorCal RMA Center Brings Nationally Recognized Success Rates, Emphasis on Research and Innovation, and Leading Physicians to More Residents of San Francisco Subway station

SAN FRANCISCO, January 23, 2023 /PRNewswire/ — Reproductive Medicine Associates (RMA) of California announced last week the opening of its new fertility center in East Bay. The center marks the third RMA location in Northern Californiajoin San Francisco and Palo Altoadding to an extensive network of clinics statewide and across the country.

The East Bay Clinic, located at 1320 El Capitan Drive in Danvillebrings the comprehensive, patient-centered approach to fertility assessment and treatment that RMA is known for, ensuring that family building goals can be achieved in one convenient place.

The full-service center will offer a range of treatments, including intrauterine insemination (IUI), in vitro fertilization (IVF), preimplantation genetic testing (PGT) and egg freezing to meet patients at no time. any stage of their fertility journey. RMA ensures that all types of families have the opportunity to grow, with resources and options for LGBTQ+ and single people to start building their families.

Scott Morin, MD, an internationally renowned infertility researcher and board-certified reproductive endocrinologist, will lead the practice. “We are excited to open an office closer to our patients in the East Bay. This office will make it easier for patients in this growing region, as well as Sacramentoand the Central Valley, to access our patient-centered approach to fertility care,” said Dr. Morin. “We take so much pride in providing highly scientific and evidence-based care, without compromising our compassionate model of care, where patients have direct access to their providers throughout their fertility journey. »

Dr. Morin is joined at the East Bay clinic by Alice Chapiro, MD, reproductive endocrinologist and member of the United States Congress of Obstetricians and Gynecologists. Specializing in LGBTQ+ patients, diminished ovarian reserve, and the fight against polycystic ovary syndrome, Dr. Shapiro believes in the patient-centered care characteristic of RMA physicians.

“With 2.7 million California residents identifying as LGBTQ+, and 23% located in the San Francisco region, there is a need for specialized fertility care for the LGBTQ+ community in Northern California“, said Dr. Shapiro. “Applying my expertise in caring for members of this community to another San Francisco-the area’s clinic with the opening of RMA East Bay, additional access and options become available to anyone looking to start or expand their family.”

Reproductive Medicine Associates’ unique embryo transfer method of placing a single, high-quality embryo in the uterus to minimize risk and improve outcomes has yielded the highest success rates in United States, with 81.2% of Northern California RMA patients under age 35 bringing home a baby, compared to the national average of 68.6% recorded by the Society for Assisted Reproductive Technologies (SART). RMA medical advances ensure that patients have access to the latest technology and the most qualified physicians to ensure the best chance of success.

As demand for reproductive medicine has grown, Reproductive Medicine Associates continues to expand, with 10 clinics opened across the country in the past five years and plans to open three more locations in 2023.

The clinic opened on January 17, 2023 and is currently scheduling patients visits. For individuals and couples concerned about funding their fertility treatments, they should check to see if their health insurance plan covers comprehensive reproductive services. If fertility treatments aren’t covered by their insurer, many employers offer additional coverage through benefit providers like Progyny.

About RMA

Reproductive Medicine Associates (RMA) has been helping build families through the most advanced treatment options and patient-centered fertility care for over 20 years. RMA is a leader in IVF research, pioneering single embryo transfer (SET), increasing safety for mother and baby, and pre-implantation genetic testing (PGT-A), dramatically increasing outcomes positive. With access to practices nationwide, RMA has helped welcome over 50,000 babies into loving families. Learn more about

Caroline Rebosio
[email protected]

SOURCE Associates in Reproductive Medicine

Leave a Comment